Distribution of the CTLA-4 single nucleotide polymorphisms CT60G>A and +49A>G in psoriasis vulgaris patients and control individuals from a Polish Caucasian population

International Journal of Immunogenetics

Volumn 35, Issue 1, 2008, Pages 51-55

  Luszczek W ^a   Majorczyk, E ^a   Nockowski, P ^b   Plucinski P ^c   Jasek, M ^a   Nowak, I ^a   Wisniewski A ^a   Kusnierczyk P ^a,d  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c 4TH MILITARY HOSPITAL   (Poland)

^d JAN DLUGOSZ UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ADULT; ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLAND; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSORIASIS VULGARIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE OF ONSET; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLAND; POLYMORPHISM, SINGLE NUCLEOTIDE; PSORIASIS;

EID: 37849008454     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2007.00736.x     Document Type: Article

References (32)

1. Anjos, S., Nguyen, A., Ounissi-Benkalha, H., Tessier, M.-C. Polychronakos, C. (2002) A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. Journal of Biological Chemistry, 277, 46478.
2. Bagos, P.G., Karnaouri, A.C., Nikolopoulos, G.K. Hamodrakas, S.J. (2007) No evidence for association of CTLA-4 gene polymorphisms with the risk of developing multiple sclerosis: a meta-analysis. Multiple Sclerosis, 13, 156.
3. van Belzen, M.J., Mulder, C.J., Zhernakova, A., Pearson, P.L., Houwen, R.H. Wijmenga, C. (2004) CTLA4 +49 and CT60 polymorphisms in Dutch coeliac disease patients. European Journal of Human Genetics, 12, 782.
4. Chong, B.F. Wong, H.K. (2007) Immunobiologics in the treatment of psoriasis. Clinical Immunology, 123, 129.
5. Heinzmann, A., Plesnar, C., Kuehr, J., Forster, J. Deichmann, K.A. (2000) European Journal of Immunogenetics, 27, 57.
6. Holopainen, P.M. Partanen, J.A. (2001) Technical note: Linkage disequilibrium and disease-associated CTLA4 gene polymorphisms. Journal of Immunology, 167, 2457.
7. Howard, T.D., Postma, D.S., Hawkins, G.A., Koppelman, G.H., Zheng, S.L., Wysong, A.K., Xu, J., Meyers, D.A. Bleecker, E.R. (2002) Fine mapping of an IgE-controlling gene on chromosome 2q: Analysis of CTLA-4 and CD28. Journal of Allergy and Clinical Immunology, 110, 743.
8. Jasek, M., Łuszczek, W., Obojski, A., Winiarska, B., Hałubek, K., Nowak, I. et al 2006) Distribution of CTLA-4 polymorphisms in allergic asthma. International Journal of Allergy and Immunology, 141, 223.
9. Kavvoura, F.K., Akamizu, T., Awata, T., Ban, Y., Chistiakov, D.A., Frydecka, I. et al 2007) CTLA-4 gene polymorphisms and autoimmune thyroid disease: a meta analysis. Journal of Clinical Endocrinology and Metabolism, 92, 3162.
10. Kim, Y.-K., Pyo, C.-W., Hur, S.-S., Kim, T.-Y. Kim, T.-G. (2003) No associations of CTLA-4 and ICAM-1 polymorphisms with psoriasis in the Korean population. Journal of Dematological Science, 33, 75.
11. Kouki, T., Sawai, Y., Gardine, C.A., Fisfalen, M.E., Alegre, M.L. DeGroot, L.J. (2000) CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. Journal of Immunology, 165, 6606.
12. Kristiansen, O.P., Larsen, Z.M. Pociot, F. (2000) CTLA-4 in autoimmune diseases - a general susceptibility gene to autoimmunity? Genes and Immunity, 1, 170.
13. Lebwohl, M. (2003) Psoriasis. The Lancet, 361, 1197.
14. Lee, S.Y., Lee, Y.H., Shin, C., Shim, J.J., Kang, K.H., Yoo, S.H. In, K.H. (2002) Association of asthma severity and bronchial hyperresponsiveness with a polymorphism in the cytotoxic T-lymphocyte antigen-4 gene. Chest, 122, 171.
15. Lew, W., Bowcock, A.M. Krueger, J.G. (2004) Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and 'Type 1' inflammatory gene expression. Trends in Immunology, 25, 295.
16. Liu, Y., Krueger, J.G. Bowcock, A.M. (2007) Psoriasis: genetic associations and immune system changes. Genes and Immunity, 8, 1.
17. Łuszczek, W., Kubicka, W., Jasek, M., Baran, E., Cisło, M., Nockowski, P., Łuczywo-Rudy, M., Wiśniewski, A., Nowak, I. Kuśnierczyk, P. (2006) CTLA-4 gene polymorphisms and natural soluble CTLA-4 protein in psoriasis vulgaris. International Journal of Immunogenetics, 33, 217.
18. Magistrelli, G., Jeannin, P., Herbault, N., Benoit De Cognac, A., Gauchat, J.F., Bonnefoy, J.Y. Delneste, Y. (1999) A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells. European Journal of Immunology, 29, 3596.
19. Maurer, M., Loserth, S., Kolb-Maurer, A., Ponath, A., Wiese, S., Kruse, N. Rieckmann, P. (2002) A polymorphism in the human cytotoxic T-lymphocyte antigen 4 gene (exon 1 +49) alters T-cell activation. Immunogenetics, 54, 1.
20. Mayans, S., Lackovic, K., Nyholm, C., Lindgren, P., Ruikka, K., Eliasson, M., Cilio, C.M. Holmberg, D. (2007) CT60 genotype does not affect CTLA-4 isoform expression despite association to T1D and AITD in northern Sweden. BMC Medical Genetic, 8, 3.
21. Munthe-Kaas, M.C., Carlsen, K.H., Helms, P.J., Gerritsen, J., Whyte, M., Feijen, M. et al 2004) CTLA-4 polymorphisms in allergy and asthma and the TH1/TH2 paradigm. Journal of Allergy and Clinical Immunology, 114, 280.
22. Nakao, F., Ihara, K., Ahmed, S., Sasaki, Y., Kusuhara, K., Takabayashi, A., Nishima, S. Hara, T. (2000) Lack of association between CD28/CTLA-4 gene polymorphisms and atopic asthma in the Japanese population. Experimental and Clinical Immunogenetics, 17, 179.
23. Oaks, M.K., Hallett, K.M., Penwell, R.T., Stauber, E.C., Warren, S.J. Tector, A.J. (2000) A native soluble form of CTLA-4. Cellular Immunology, 201, 144.
24. Pawlak, E., Kochanowska, I.E., Frydecka, I., Kiełbiński, M., Potoczek, S. Bilińska, M. (2005) The soluble CTLA-4 receptor: a new marker in autoimmune diseases. Archivum Immunologiae et Therapiae Experimentalis, 53, 336.
25. Perez-Garcia, A., De la Camara, R., Roman-Gómez, J., Jimenez-Velasco, A., Encuentra, M., Nieto, J.B. et al 2007) CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors. Blood, 110, 461.
26. Purohit, S., Podolsky, R., Collins, C., Zheng, W., Schatz, D., Muir, A., Hopkins, D., Huang, Y.-H. She, J.-X. (2005) Lack of correlation between the levels of soluble cytotoxic T-lymphocyte asociated antigen-4 (CTLA-4) and the CT-60 genotypes. Journal of Autoimmune Diseases, 2, 8.
27. Riley, J.L. June, C.H. (2005) The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation. Blood, 105, 13.
28. Sohn, M.H., Kim, S.H., Song, T.W., Kim, K.W., Kim, E.S., Park, H.S. Kim, K.E. (2007) Cytotoxic T lymphocyte-associated antigen-4 gene polymorphisms confer susceptibility to atopic asthma in Korean children. Pediatric Pulmonology, 42, 542.
29. Teft, W.A., Kirchhof, M.G. Madrenas, J. (2006) A molecular perspective of CTLA-4 function. Annual Review of Immunology, 24, 65.
30. Tsunemi, Y., Saeki, H., Kishimoto, M., Mitsui, H., Tada, Y., Torii, H., Komine, M., Asahina, A., Tamaki, K. Sekiya, T. (2003) Cytotoxic T lymphocyte antigen-4 gene (CTLA-4) polymorphisms in Japanese patients with psoriasis vulgaris. Journal of Dermatological Science, 32, 163.
31. Ueda, H., Howson, J.M.M., Esposito, L., Heward, J., Snook, H., Chamberlain, G. et al 2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature, 423, 506.
32. Yang, K.D., Liu, C.A., Chang, J.C., Chuang, H., Ou, C.Y., Hsu, T.Y. Wang, C.L. (2004) Polymorphism of the immune-braking gene CTLA-4 (+49) involved in gender discrepancy of serum total IgE levels and allergic diseases. Clinical and Experimental Allergy, 34, 32.